Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and social businesses; and invests in biotechnology related businesses. Further, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.
Frequently asked questions
What sector does Euglena Co Ltd (2931) operate in?
Euglena Co Ltd belongs to the Consumer Staples sector and operates in the Household & Personal Products industry.
What is Euglena Co Ltd (2931) current stock price?
As of the latest data, Euglena Co Ltd stock price is ¥338, with a previous close of ¥346. Euglena Co Ltd lost -¥8 in the last trading session, representing a -2.31% loss.
What is Euglena Co Ltd (2931) current market capitalization?
Euglena Co Ltd market cap is approximately 47.15 billion.
What is Euglena Co Ltd (2931) Earnings Per Share (EPS)?
The trailing EPS is -¥1, and the forward EPS is ¥4.
What is Euglena Co Ltd (2931) EBITDA?
Euglena Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.85 billion.
Does Euglena Co Ltd (2931) pay dividends?
Yes. Euglena Co Ltd pays annual dividends with an annualized yield of 0.59% and an estimated annual payout of ¥2 per share.
When is the next ex-dividend date for Euglena Co Ltd (2931)?
The next ex-dividend date is scheduled for December 29, 2026.
What is Euglena Co Ltd (2931) beta (volatility) score?
Euglena Co Ltd has a beta of -0.053, indicating lower volatility than the overall market.
